Breaking News
Subscribe Now 0
🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screener
Try Stock Screener
Close

Ab - International Health Care Portfolio I Acc (0P00000V0F)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
657.950 -8.160    -1.23%
31/10 - Closed. Currency in EUR
  • Morningstar Rating:
  • Total Assets: 3.74B
Type:  Fund
Market:  Luxembourg
Issuer:  AllianceBernstein (Luxembourg) S.à r.l.
ISIN:  LU0251855366 
Asset Class:  Equity
AB SICAV I - International Health Care Portfolio I 657.950 -8.160 -1.23%

0P00000V0F Overview

 
On this page you'll find an in-depth profile of Ab - International Health Care Portfolio I Acc. Learn about the key management, total assets, investment strategy and contact information of 0P00000V0F among other information.
Category

Sector Equity Healthcare

Total Assets

3.74B

Expenses

1.17%

Inception Date

Feb 18, 1999

Investment Strategy

The Portfolio seeks to increase the value of your investment over time through capital growth. Under normal market conditions, the Portfolio typically invests at least 80%, and not less than two thirds, of its assets in equity securities of companies in health care and health care-related industries. These companies may be located anywhere in the world, including Emerging Markets. The Portfolio may be exposed to any currency.

Contact Information

Address One International Finance Centre
Hong Kong, L-2453
Hong Kong
Phone +352 46 39 36 151

Top Executives

Name Title Since Until
John H. Fogarty Senior Vice President 2019 Now
Biography John H. Fogarty is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the US, having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Vardon Partners. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Fogarty holds a BA in history from Columbia University and is a CFA charterholder. Location: New York
Vinay Thapar Senior Vice President 2013 Now
Biography Vinay Thapar is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities and a Portfolio Manager for the Global Healthcare Strategy. He is also a Senior Research Analyst, responsible for covering global healthcare. Before joining the firm in 2011, Thapar spent three years at American Century Investments as a senior investment analyst responsible for healthcare. Prior to that, he worked for eight years at Bear Stearns in the Biotech Equity Research Group, most recently as an associate director. Thapar holds a BA in biology from New York University and is a CFA charterholder. Location: New York
John H. Fogarty Senior Vice President 2013 2018
Biography John H. Fogarty is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the US, having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Vardon Partners. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Fogarty holds a BA in history from Columbia University and is a CFA charterholder. Location: New York
Bryce Hill - 2013 2015
Biography Mr. Hill is portfolio manager for the Disciplined Value strategy. He heads the global Health Care sector team and is a senior research analyst for the firm’s value/core equity strategies focusing on the health care and technology sectors. Mr. Hill is a CFA charterholder and holds an MBA from Columbia University and a BS in Business Administration, summa cum laude, from the University of Southern California.
Tassos M. Stassopoulos Senior Vice President 2011 2013
Biography "Sector Head—Global/International Research Growth Tassos Stassopoulos is the Global/International Research Growth Sector Head for the consumer sector. He joined AllianceBernstein in 2007 as a research analyst covering retail, luxury, food and leisure/pubs in Europe. Stassopoulos was named the International Research Growth Sector Head for consumer in January 2009 and the Global Research Growth Sector Head for consumer in March 2011. Prior to joining the firm, Stassopoulos was a managing director at Credit Suisse for seven years, six of which he spent as a senior analyst and sector head for pan-European travel and leisure coverage. While there, he was twice ranked #1 in the Institutional Investor survey of analysts in his sector. In his last year at Credit Suisse, Stassopoulos was a portfolio manager at the firm’s internal hedge fund, Modal Capital. He also spent eight years as a management consultant at Arthur Andersen, where he specialized in lodging and gaming. Stassopoulos is a graduate of Cambridge University, St. John’s College, and a member of the Institute of Chartered Accountants. Location: London "
Steven Nussbaum - 2007 2012
Biography Dr. Nussbaum manages the AllianceBernstein Healthcare Funds and is also the Healthcare Sector Head for Global Research Growth. Prior to joining Alliance Capital in 2002, Dr. Nussbaum worked as a Medical Products analyst at JP Morgan from 1999-2002. Prior to coming to Wall Street, he was an attending physician and a Clinical Assistant Professor of Radiology at Thomas Jefferson University Hospital in Philadelphia and before that he was an attending physician at Long Island Jewish Medical Center in New York. Dr. Nussbaum completed a radiology fellowship at Thomas Jefferson University Hospital, a radiology residency at Montefiore Medical Center in New York, and a medical internship at Danbury Hospital in Connecticut. He holds a BA from Harvard University, an MD from the Albert Einstein College of Medicine, and an MBA from the NYU Stern School of Business.
Norman M. Fidel Senior Vice President 1995 2007
Biography Fidel is a senior vice president of AllianceBernstein. He joined the firm from Eberstadt Asset Management, where he served as a senior vice president and the director of research. Prior to that, he was a security analyst with Irving Trust Company. Fidel is a member of the New York Society of Security Analysts and the Health Industries Analyst Group of New York.
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00000V0F Comments

Write your thoughts about Ab - International Health Care Portfolio I Acc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email